{"id":130129,"date":"2024-08-02T13:47:32","date_gmt":"2024-08-02T08:17:32","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=130129"},"modified":"2024-08-02T13:51:09","modified_gmt":"2024-08-02T08:21:09","slug":"pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/","title":{"rendered":"Pharma stock jumps 3.3% after company&#8217;s board approves 2:1 bonus issue \u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-4205651903\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2638427543\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>With a market capitalisation of Rs. 74.02 crores, at 12:53 p.m., the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/JFLLIFE\/standalone\" target=\"_blank\" rel=\"noreferrer noopener\">JFL Life Sciences Limited<\/a><\/strong> were trading in the green at Rs. 67.3, up by 3.3 percent, from the previous closing price of Rs. 65.15.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What\u2019s the News:&nbsp;<\/strong><\/h2><p>According to the latest regulatory filings with the NSE, the meeting of the Board of Directors of JFL Life Sciences held on 2nd August approved the proposal of raising of funds and issue of Bonus shares.&nbsp;<\/p><p>The Board has approved the proposal of fundraising through a Rights issue, Further issue, Preferential issue of equity shares, or a combination of these methods, for an amount not exceeding Rs. 50 crore.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1544906923\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Additionally, the Board has recommended the issue of Bonus Shares in a 2:1 ratio, meaning shareholders will receive 2 new bonus equity shares of the face value of Rs. 10, for every 1 equity share held. The record date for this issuance will be declared in due course.&nbsp;<\/p><p>The Board also recommended a final dividend of Rs. 0.25 per equity share for the financial year ended March 31, 2024, subject to the approval of the shareholders.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also read<\/strong><\/p><\/blockquote><figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"ctZdIFvTMv\"><a href=\"https:\/\/tradebrains.in\/features\/green-energy-stock-jumps-9-after-receiving-orders-worth-53-23-cr-from-multiple-clients\/\">Green energy stock jumps 9% after receiving orders worth \u20b9 53.23 Cr from multiple clients<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Green energy stock jumps 9% after receiving orders worth \u20b9 53.23 Cr from multiple clients&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/green-energy-stock-jumps-9-after-receiving-orders-worth-53-23-cr-from-multiple-clients\/embed\/#?secret=hC5F9lX9wB#?secret=ctZdIFvTMv\" data-secret=\"ctZdIFvTMv\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Previous News:&nbsp;<\/strong><\/h2><p>On July 8th, JFL Life Sciences launched 16 new products to serve the domestic market for the first time under the \u201cMake In India\u201d campaign. These products, carrying the tagline \u201cJust for Life,\u201d include tablets, capsules, gels, syrups, creams, and injections.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials:&nbsp;<\/strong><\/h2><p>The company experienced significant growth in its revenue from operations, showing a year-on-year rise of 8.7 percent from Rs. 42.83 crores in FY22-23 to Rs. 46.55 crores in FY23-24.&nbsp;<\/p><p>Similarly, its net profit increased during the same period from Rs. 2.8 crores to Rs. 3.3 crores, indicating a growth of around 17.8 percent YoY.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company:<\/strong><\/h2><p>Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of producing and marketing a wide range of pharmaceutical products and has manufacturing facilities with trading and related activities extending to the global market.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-1900131269\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The product portfolio of the company consists of dry powder injections (B-Lactam), tablets &amp; capsules (B-Lactam) solid oral dosage forms tablets and capsules (general) solid oral dosage forms, and oral rehydration solutions (ORS).&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Shivani Singh&nbsp;<\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2132254002\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.&nbsp; With a market capitalisation of Rs. 74.02 crores, at 12:53 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[21121,20310,20309,6616,948,936],"class_list":["post-130129","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-jfl-life-sciences-bonus-issue","tag-jfl-life-sciences-latest-news","tag-jfl-life-sciences-share-price","tag-pharma-stock","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 3.3% after company&#039;s board approves 2:1 bonus issue \u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 3.3% after company&#039;s board approves 2:1 bonus issue \u00a0\" \/>\n<meta property=\"og:description\" content=\"In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-02T08:17:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-02T08:21:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/\",\"name\":\"Pharma stock jumps 3.3% after company's board approves 2:1 bonus issue \u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-08-02T08:17:32+00:00\",\"dateModified\":\"2024-08-02T08:21:09+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 3.3% after company&#8217;s board approves 2:1 bonus issue \u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 3.3% after company's board approves 2:1 bonus issue \u00a0 - Trade Brains Features","description":"In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 3.3% after company's board approves 2:1 bonus issue \u00a0","og_description":"In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-08-02T08:17:32+00:00","article_modified_time":"2024-08-02T08:21:09+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/","name":"Pharma stock jumps 3.3% after company's board approves 2:1 bonus issue \u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-08-02T08:17:32+00:00","dateModified":"2024-08-02T08:21:09+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"In Friday\u2019s trading session, the shares of a company engaged in manufacturing pharmaceutical products surged by 5 percent to reach a new 52-week high of Rs. 68.4. This increase followed the company\u2019s Board approval of a 2:1 bonus issue and a Rs. 50 crore fundraise.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-3-after-companys-board-approves-21-bonus-issue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 3.3% after company&#8217;s board approves 2:1 bonus issue \u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/130129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=130129"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/130129\/revisions"}],"predecessor-version":[{"id":130133,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/130129\/revisions\/130133"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=130129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=130129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=130129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}